Currently, 10+ Key Companies are Working to Develop 10+ Pipeline Therapies for the Lymphoedema Treatment

"Lymphoedema Pipeline Insight, 2022" report by DelveInsight provides a comprehensive analysis of the ongoing clinical development activities and growth prospects across the Lymphoedema Therapeutics Market.

In the report, a detailed description of the drug is proffered, including the mechanism of action, type, stage, route of administration, molecule type, clinical studies, inactive pipeline products, and NDA approvals (if any).

The report also covers in-depth commercial and clinical activities of the pipeline products from the pre-clinical developmental phase to the marketed phase. Additionally, it presents the ongoing developments in the therapeutics segment including collaborations, licensing, mergers & acquisitions (M&A), funding, designations, and other product-related details.

Lymphoedema Pipeline Analysis
The report provides insights into:
The report provides detailed insights about companies that are developing therapies in the Lymphoedema Market.
It accesses the different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Lymphoedema treatment.

Lymphoedema key companies involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
Lymphoedema Drugs that are under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement, and financing details for future advancement of the Lymphoedema market.

The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.

Request for Sample PDF: https://www.delveinsight.com/report-store/lymphoedema-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Lymphoedema Therapeutics Analysis
There are approx. 10+ key companies which are developing therapies for Lymphoedema. The companies which have their Lymphoedema drug candidates in the most advanced stage, i.e. phase II include, Herantis Pharma.

Some of the key companies in the Lymphoedema Therapeutics Market include:
Herantis Pharma
PureTech health
AnGes
Adepthera
And others

Lymphoedema Emerging Drugs
Currently, more than 10+ Pipeline therapies are under development for the treatment of Lymphoedema. The therapies are in different stages of clinical development, expected to hit the market in the coming years.

Lymfactin: Herantis Pharma
Lymfactin is currently in Phase 2 trial clinical study. It is being developed by Herantis Pharma. It is a gene therapy product, which delivers the human gene coding for VEGF-C and thereby promotes the formation of new lymphatic vessels.

Learn more about the emerging therapies in the Lymphoedema Therapeutics Market, at:
https://www.delveinsight.com/sample-request/lymphoedema-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Table of Content
1. Report Introduction
2. Executive Summary
3. Lymphoedema Current Treatment Patterns
4. Lymphoedema - DelveInsight's Analytical Perspective
5. Therapeutic Assessment
6. Lymphoedema Late Stage Products (Phase-III)
7. Lymphoedema Mid Stage Products (Phase-II)
8. Early Stage Products (Phase-I)
9. Pre-clinical Products and Discovery Stage Products
10. Inactive Products
11. Dormant Products
12. Lymphoedema Discontinued Products
13. Lymphoedema Product Profiles
14. Lymphoedema Key Companies
15. Lymphoedema Key Products
16. Dormant and Discontinued Products
17. Lymphoedema Unmet Needs
18. Lymphoedema Future Perspectives
19. Lymphoedema Analyst Review
20. Appendix
21. Report Methodology
*The table of contents is not exhaustive; the final content may vary.

Request for the Sample PDF (to get a detailed understanding of the TOC, Tables, and Figures included in the report), at: https://www.delveinsight.com/report-store/lymphoedema-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr

Contact Info:
Anuj Rawat
Email: info@delveinsight.com
https://www.delveinsight.com/
Request for Sample Copy of the Report at:
https://www.delveinsight.com/sample-request/lymphoedema-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=rpr
428, D21 Corporate Park, Sector-21, Dwarka, New Delhi-110077, India

About DelveInsight
DelveInsight is a leading Business Consultant and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing end-to-end comprehensive solutions to improve their performance.

This release was published on openPR.